Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 459,757 |
|
|||||
| News | (1) | ||||||
| Day High | 21.335 | Low High |
|||||
| Day Low | 19.34 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aerovate Therapeutics Inc | AVTE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.83 | 4.17% | 20.74 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 19.34 | 19.34 | 21.335 | 20.74 | 19.91 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,389 | 459,757 | $ 20.38 | $ 9,370,922 | - | 9.41 - 32.415 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:14:20 | 18 | $ 20.79 | USD |
Aerovate Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 573.3M | 27.67M | - | 0 | -75.52M | -2.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aerovate Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVTE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.80 | 21.335 | 15.76 | 18.34 | 352,976 | 2.94 | 16.52% |
| 1 Month | 21.68 | 22.48 | 15.52 | 18.71 | 256,807 | -0.94 | -4.34% |
| 3 Months | 24.41 | 32.415 | 15.52 | 22.57 | 201,892 | -3.67 | -15.03% |
| 6 Months | 16.40 | 32.415 | 15.52 | 21.78 | 146,139 | 4.34 | 26.46% |
| 1 Year | 16.30 | 32.415 | 9.41 | 19.25 | 112,960 | 4.44 | 27.24% |
| 3 Years | 28.00 | 32.415 | 7.74 | 18.60 | 102,750 | -7.26 | -25.93% |
| 5 Years | 28.00 | 32.415 | 7.74 | 18.60 | 102,750 | -7.26 | -25.93% |
Aerovate Therapeutics Description
| Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. |
